Research news

New advances in the improvement of the design of drugs against glial globular taupathy

José Antonio del Río, principal investigator at the Institute for Bioengineering of Catalonia (IBEC) together with Dr. Isidre Ferrer from Bellvitge Biomedical Research Institute (IDIBELL) led a study where they have unraveled that the pathology shown by patients with Globular Glial Tauopathy is due to the generation of harmful protein deposits for neurons and glial cells.

Tauopathies are characterized by the accumulation of phosphorylated tau protein, that associates with phosphate groups.

Read more…

Other news

The EMBL-IBEC Winter Conference comes to an end with a huge success in terms of participation

This week, the conference organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) brought together a total of 200 international experts in the field of bioengineering at La Pedrera building in Barcelona.

At the opening of the event, which was led by the mayor of Barcelona, Ada Colau, attention was drawn to Barcelona’s consolidation as an international centre of research and knowledge.

Read more…